ArticleGene therapy2020

'Mini' U6 Pol III promoter exhibits nucleosome redundancy and supports multiplexed coupling of CRISPR/Cas9 effects.

Roland Preece et al.PubMed ↗Publisher ↗

No numbers read from the abstract.